Maintenance window scheduled to begin at February 14th 2200 est. until 0400 est. February 15th
MRF-D 24.3 U.S. Navy personnel support Melioidosis research study, develop medical support strategies in the Indo-Pacific
Marine Rotational Force - Darwin
Visit news Page
The Rebel with a Mysterious Cause
Courtesy Story
Defense Threat Reduction Agency's Chemical and Biological Technologies Department
Visit news Page
The Smell of Victory: Aerosolized Melioidosis Vaccine in Development
Courtesy Story
Defense Threat Reduction Agency's Chemical and Biological Technologies Department
Visit news Page
Today’s Forecast: Cloudy With A Chance of Melioidosis
Courtesy Story
Defense Threat Reduction Agency's Chemical and Biological Technologies Department
Visit news Page
Of Mice to Men: First Melioidosis Vaccine on the Horizon
Courtesy Story
Defense Threat Reduction Agency's Chemical and Biological Technologies Department
Visit news Page
Putting the Pieces Together: Solving the Burkholderia Puzzle
Courtesy Story
Defense Threat Reduction Agency's Chemical and Biological Technologies Department
Visit news Page
Old Antibiotics, New Tricks to Combat Bio Agents
Courtesy Story
Defense Threat Reduction Agency's Chemical and Biological Technologies Department
Visit news Page
Networking Across Continents for New Melioidosis Countermeasures
Courtesy Story
Defense Threat Reduction Agency's Chemical and Biological Technologies Department
Visit news Page